Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1–7) levels in experimental biliary fibrosis()

BACKGROUND/AIMS: Angiotensin-converting enzyme 2 (ACE2), its product, angiotensin-(1–7) and its receptor, Mas, may moderate the adverse effects of angiotensin II in liver disease. We examined the expression of these novel components of the renin angiotensin system (RAS) and the production and vasoac...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Hepatol
Autori principali: Herath, Chandana B., Warner, Fiona J., Lubel, John S., Dean, Rachael G., Jia, Zhiyuan, Lew, Rebecca A., Smith, A. Ian, Burrell, Louise M., Angus, Peter W.
Natura: Artigo
Lingua:Inglês
Pubblicazione: European Association for the Study of the Liver. Published by Elsevier Ireland Ltd. 2007
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7114685/
https://ncbi.nlm.nih.gov/pubmed/17532087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhep.2007.03.008
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi